FountainBlue Life Science January 25, 2010

FountainBlue's Life Science Angel Investors Panel: Trends for 2010
Life science angel investors are generally seasoned executives with deep strategic and operational experience in running successful life science businesses, from concept to clinical trials to regulatory approvals, manufacturing and distribution. They generally also have extensive experience within corporations in various roles, and continue to develop these partnerships as they support their portfolio companies.

The life science angel investors panelists have been seen a wide range of life science business models, and have their own thoughts and recommendations on how to be successful in these challenging times. Topics will include how early stage companies can position themselves for successful partnerships and fundings, strategically plan your business based on evolving market needs, tightly manage cash flow, and build strategic alliances with larger organizations, angels, research organizations, and other key stakeholders. Our panel will feature:

Facilitator Conor Moore, Partner, KPMG

Panelist Anne DeGheest, Founder and Managing Director, MedStars, Strategic Advisor at PolyRemedy, Inc

Panelist Stuart Eckmann, Keiretsu Forum and Life Science Angels

Panelist Don Ross, Member, Life Science Angels and Sand Hill Angels

Panelist Michael Weickert, President and CEO, S.E.A. Medical Systems, Inc., Member, Life Science Angels, Venture Partner, Kranenburg Fund

As part of this month’s program, we will solicit feedback from all our attendees on the challenges and opportunities in through facilitated small groups, based on life science sub-industry topics: Software solutions for the healthcare industry, medical devices, personalized medicine, medical imaging, and biopharma.

Information and Registration: NO SERVICE PROVIDERS PLEASE.
• Additional information about our life science entrepreneurs forum and notes from our previous meetings are available at http://www.SVLifeScience.com.